Is bleomycin-detectahle iron present in the plasma of patients with septic shock?

Intensive Care Medicine

Volumn 23, Issue 6, 1997, Pages 635-639

  Mumby, S ^a,b   Margarson, M ^c   Quinlan, G J ^a,b   Evans, T W ^a,b   Gutteridge, J M C ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Bleomycin detectable iron; Iron overload; Non haem iron; Septicaemia

Indexed keywords

BLEOMYCIN; IRON; TRANSFERRIN; BIOLOGICAL MARKER; IRON CHELATING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MULTIPLE ORGAN FAILURE; SEPTIC SHOCK; TRANSFERRIN BLOOD LEVEL; APACHE; BLOOD; CASE CONTROL STUDY; FEMALE; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

ADULT; APACHE; BIOLOGICAL MARKERS; BLEOMYCIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; IRON; IRON CHELATING AGENTS; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC;

EID: 0030610891     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340050386     Document Type: Article

References (14)

1. Tate RM, Repine JE (1983) Neutrophils and the adult respiratory distress syndrome. Am Rev Resp Dis 125: 552-559
2. Gutteridge JMC, Quinlan GJ, Mumby S, Heath A, Evans TW (1994) Primary plasma antioxidant in adult respiratory distress syndrome patients: Changes in iron-oxidising, iron-binding, and free radical-scavenging proteins. J Lab Clin Med 124: 263-273
3. Gutteridge JMC, Rowley DA, Halliwell B (1981) Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 199: 263-265
4. Gutteridge JMC, Halliwell B (1987) Radical-promoting loosely bound iron in biological fluids and the bleomycin assay. Life Chem Reports 4: 113-142
5. Gutteridge JMC (1996) The bleomycin assay for low molecular mass, chelatable redox active iron in biological samples. In: Griffiths E, Bullen JJ (eds) Iron and infection, physiological and clinical aspects. 2nd edn Wiley, Chichester (In press)
6. Bullen JJ, Griffiths E (eds) (1987) Iron and infection molecular, physiological and clinical aspects. Wiley, Chichester
7. Galley HF, Webster NR (1996) Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome. Intensive Care Med 22: 226-229
8. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA, et al. (1989) Sepsis syndrome: a valid clinical entity. Crit Care Med 17: 389-393
9. Kraus WA (1996) The use and severity scoring system in clinical investigations of seriously ill patients. In: Evans TW, Hinds CJ (eds) New advances in Critical Care Medicine, 4. Churchill Livingstone, London, pp 191-212
10. Gutteridge JMC, Hou Y (1986) Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely bound iron. Free Radic Res Commun 2: 143-151
11. Boyne AF, Ellman GL (1972) A methodology for analysis of tissue sulfhydryl compounds. Anal Biochem 46: 639-657
12. Gutteridge JMC, Quinlan GJ, Evans TW (1994) Transient iron overload with bleomycin-detectable iron in the plasma of patients with adult respiratory distress syndrome. Thorax 49: 707-710
13. Weinberg ED (1993) The iron-withholding defense system. Am Soc Microbiol News 59: 559-562
14. Messant M, Sinclair DG, Quinlan GJ, Mumby S, Gutteridge JMC, Evans TW (1996) Pulmonary vascular permeability following cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med (In press)